.

BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Medtronic
Federal Trade Commission
Chinese Patent Office
Queensland Health
Covington
McKesson
Teva
Moodys
Novartis

Generated: February 18, 2018

DrugPatentWatch Database Preview

US Patents With Foreign Priority to Sweden Patent: 9803929

« Back to Dashboard


Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Valeant BermudaXERESEacyclovir; hydrocortisoneCREAM;TOPICAL022436-001Jul 31, 2009RXYesYes➤ Try a Free Trial➤ Try a Free TrialYCOMBINATION PRODUCT FOR THE EARLY TREATMENT OF RECURRENT HERPES LABIALIS (COLD SORES) TO REDUCE THE LIKELIHOOD OF ULCERATIVE COLD SORES AND TO SHORTEN THE LESION HEALING TIME IN ADULTS AND CHILDREN (6 YEARS OF AGE AND OLDER)
Valeant BermudaXERESEacyclovir; hydrocortisoneCREAM;TOPICAL022436-001Jul 31, 2009RXYesYes➤ Try a Free Trial➤ Try a Free TrialYNEW COMBINATION PRODUCT FOR THE EARLY TREATMENT OF RECURRENT HERPES LABIALIS (COLD SORES) TO REDUCE THE LIKELIHOOD OF ULCERATIVE COLD SORES AND TO SHORTEN THE LESION HEALING TIME IN ADULTS AND ADOLESCENTS (12 YEARS OF AGE AND OLDER)
This preview shows a limited number of results
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Table 'thinkbio_newdpw.patent_gazette' doesn't exist